Amgen Chairman and CEO Robert Bradway speaks at a company celebration at its Thousand Oaks headquarters on Oct. 12. (Mike Harris / PCBT Staff) Thousand Oaks-based Amgen has a lot on the horizon as it nears the end of fiscal year 2023, with the company yet again beating analysts' expectations, this time in the third…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
